跳至主要内容
临床试验/DRKS00029012
DRKS00029012招募中不适用

Prospective investigation of the morphology-based risk score for colon carcinoma stratification - MBR

niversitätsklinikum Augsburg0 个研究点目标入组 300 人开始时间: 2022年8月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • (1) Initial diagnosis of untreated colon carcinoma (NOS), UICC stage I – II, R0
  • (2) Treatment in the University Hospital Augsburg or in one of the partner hospitals
  • (3) Availability of sufficient tumor material (paraffin block and/or fresh tissue) or sections
  • (4) Written consent from the patient to participate in the study

排除标准

  • (1) Neoadjuvant therapy of colon carcinoma
  • (2) Patients unable to consent
  • (3) Insufficient understanding of the German language
  • (4) Patients with chronic inflammatory bowel disease
  • (5) Patients with hereditary colorectal cancer syndromes (such as Lynch syndrome, familial adenomatous polyposis)

研究者

发起方
niversitätsklinikum Augsburg

相似试验

Prospective investigation of the morphology-based... | 临床试验